Alphatec (ATEC) Getting Somewhat Positive News Coverage, Accern Reports

News coverage about Alphatec (NASDAQ:ATEC) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Alphatec earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned media coverage about the medical technology company an impact score of 46.1483576117982 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Several brokerages have issued reports on ATEC. ValuEngine lowered Alphatec from a “sell” rating to a “strong sell” rating in a research note on Friday. HC Wainwright restated a “buy” rating and set a $4.00 price objective on shares of Alphatec in a report on Wednesday, November 22nd. Finally, Lake Street Capital assumed coverage on Alphatec in a report on Monday, October 16th. They set a “buy” rating and a $7.00 price objective for the company.

Shares of Alphatec (NASDAQ ATEC) traded down $0.05 during trading on Tuesday, reaching $2.60. The company had a trading volume of 109,400 shares, compared to its average volume of 97,691. Alphatec has a 1-year low of $1.58 and a 1-year high of $5.80. The company has a quick ratio of 1.08, a current ratio of 2.11 and a debt-to-equity ratio of -1.11.

ILLEGAL ACTIVITY NOTICE: This story was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://www.dispatchtribunal.com/2017/12/05/alphatec-atec-getting-somewhat-positive-news-coverage-accern-reports.html.

Alphatec Company Profile

Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.

Insider Buying and Selling by Quarter for Alphatec (NASDAQ:ATEC)

Receive News & Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply